Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Post by dt_coreon Mar 20, 2024 4:02pm
120 Views
Post# 35943559

Speculative Theory

Speculative TheoryThis post is just for fun so take it with a grain of salt:

1. If the Go Shop period ended without a bidder emerging then the company would enter a No Shop which is a material event necessitating a press release to inform shareholders.
2. If the Go Shop resulted in a formal bid then Beedie would be given 7 business days to respond and at the same time the company would have to press release the bid to inform shareholders.
3. If the Go Shop surfaced an interested bidder BUT negotiations were still ongoing with the company then - THNK would be free to continue negotiations with the potential bidder as part of Fiduciary Out provisions. Continuing negotiations are not considered a material event that the company needs to inform shareholders about (according to Canadian legal experts)
4. Well Health Technologies (WELL:TSX) has long been rumoured to be a logical acquirer of THNK given the strong strategic fit with their business. WELL reports Q4 2023 tomorrow morning.

Could WELL be a potential bidder? If so they would likely offer stock or a combination of cash/stock. THNK shareholders would want (possibly need) to see WELL financials in order to make an informed deciision on whether to accept the WELL stock offer. Thus I'm speculating with no backing whatsoever that the reason we haven't seen an update on THNKs Go Shop is that the company is continuing negotiations with a potential bidder that surfaced during the Go Shop, and that bidder is WELL, and the signed formal agreement is contingent on Q4 2023 results being published.

Total speculation. We will know shortly.

<< Previous
Bullboard Posts
Next >>